Please provide your email address to receive an email when new articles are posted on . Subtrochanteric fractures of the femur can challenge even the experienced surgeon and preoperative assessment ...

This interesting study shows that the incidence of more rare femoral fractures such as subtrochanteric fractures was stable from 1996 to 2006, although the overall incidence of hip fracture is ...

This page lists all known medications that could potentially lead to 'Subtrochanteric Femur Fracture' as a side effect. It's important to note that mild side effects are quite common with medications.

Please provide your email address to receive an email when new articles are posted on . “The biggest thing with the intertrochanteric and subtrochanteric fractures is to get it right the first time.

Older women who used bisphosphonates (medications that prevent loss of bone mass) for five years or more were more likely to experience "atypical" fractures involving the femoral shaft or ...

A new position paper on "atypical" subtrochanteric fractures in association with long-term treatment with bisphosphonates examines available evidence which indicates that the proven benefits of ...

Atypical fractures of the femur associated with long-term bisphosphonate use can be distinguished by their distinct fracture pattern. These types of fractures generally are low-impact injuries that ...

However, the investigators are not recommending stopping use of bisphosphonates in appropriate patients. They note that the absolute risk for atypical fractures is low and that the benefits of ...

Since 2007, there have been several reports suggesting a potential association between the use of bisphosphonates and the occurrence of subtrochanteric or so-called atypical femoral fracture. 1–4 ...

[03-10-2010] Patients and healthcare professionals may have questions about oral bisphosphonate medications and atypical subtrochanteric femur fractures - fractures in the bone just below the hip ...

The long-term safety of bisphosphonates for the treatment of osteoporosis has been questioned. Two case series have suggested a link between prolonged bisphosphonate therapy and atypical fractures. In ...

(Corrects to show Actonel is owned by Warner Chilcott, 4th paragraph) * FDA says no thigh fracture risk with bisphosphonates * Bisphosphonates such as Fosamax treat osteoporosis * FDA statement ...